{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:26:29Z","timestamp":1791278789840,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1124\/mol.105.020057","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T01:40:12Z","timestamp":1137634812000},"page":"1461-1467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["The Anti-Yellow Fever Virus Activity of Ribavirin Is Independent of Error-Prone Replication"],"prefix":"10.1016","volume":"69","author":[{"given":"Pieter","family":"Leyssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.105.020057_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0042-6822(03)00144-2","article-title":"Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis","volume":"311","author":"Airaksinen","year":"2003","journal-title":"Virology"},{"key":"10.1124\/mol.105.020057_bib2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jhep.2005.05.032","article-title":"Mutagenic effects of ribavirin and response to interferon\/ribavirin combination therapy in chronic hepatitis C","volume":"43","author":"Asahina","year":"2005","journal-title":"J Hepatol"},{"key":"10.1124\/mol.105.020057_bib3","doi-asserted-by":"crossref","first-page":"24591","DOI":"10.1016\/S0021-9258(19)74507-4","article-title":"Eicar (5-ethynyl-1-\u03b2-d-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis","volume":"268","author":"Balzarini","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.020057_bib4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/978-1-4615-5381-6_139","article-title":"Metabolism of EICAR (5-ethynyl-1-beta-d-ribofuranosylimidazole-4-carboxamide), a potent inhibitor of inosinate dehydrogenase","volume":"431","author":"Balzarini","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/mol.105.020057_bib5","doi-asserted-by":"crossref","first-page":"35638","DOI":"10.1074\/jbc.M400460200","article-title":"A structural basis for the inhibition of the NS5 dengue virus mRNA 2\u2032-O-methyltransferase domain by ribavirin 5\u2032-triphosphate","volume":"279","author":"Benarroch","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.020057_bib6","doi-asserted-by":"crossref","first-page":"22124","DOI":"10.1074\/jbc.M400908200","article-title":"The broad spectrum antiviral nucleoside ribavirin as a substrate for a viral RNA capping enzyme","volume":"279","author":"Bougie","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.020057_bib7","doi-asserted-by":"crossref","first-page":"8505","DOI":"10.1128\/JVI.76.17.8505-8517.2002","article-title":"Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system","volume":"76","author":"Contreras","year":"2002","journal-title":"J Virol"},{"key":"10.1124\/mol.105.020057_bib8","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1073\/pnas.111085598","article-title":"RNA virus error catastrophe: direct molecular test by using ribavirin","volume":"98","author":"Crotty","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.105.020057_bib9","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/82191","article-title":"The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen","volume":"6","author":"Crotty","year":"2000","journal-title":"Nat Med"},{"key":"10.1124\/mol.105.020057_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.antiviral.2005.04.002","article-title":"Error-prone replication of West Nile virus caused by ribavirin","volume":"67","author":"Day","year":"2005","journal-title":"Antiviral Res"},{"key":"10.1124\/mol.105.020057_bib11","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1096\/fasebj.10.8.8666162","article-title":"Basic concepts in RNA virus evolution","volume":"10","author":"Domingo","year":"1996","journal-title":"FASEB J"},{"key":"10.1124\/mol.105.020057_bib12","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/genetics\/148.4.1667","article-title":"Rates of spontaneous mutation","volume":"148","author":"Drake","year":"1998","journal-title":"Genetics"},{"key":"10.1124\/mol.105.020057_bib13","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1128\/AAC.11.6.946","article-title":"Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate","volume":"11","author":"Eriksson","year":"1977","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.105.020057_bib14","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/0006-291X(79)91853-9","article-title":"The broad spectrum antiviral agent ribavirin inhibits capping of mRNA","volume":"89","author":"Goswami","year":"1979","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.105.020057_bib15","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1128\/JVI.75.17.8074-8081.2001","article-title":"Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes","volume":"75","author":"Lanford","year":"2001","journal-title":"J Virol"},{"key":"10.1124\/mol.105.020057_bib16","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/JVI.79.3.1943-1947.2005","article-title":"The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase","volume":"79","author":"Leyssen","year":"2005","journal-title":"J Virol"},{"key":"10.1124\/mol.105.020057_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1128\/CMR.13.1.67","article-title":"Perspectives for the treatment of infections with Flaviviridae","volume":"13","author":"Leyssen","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1124\/mol.105.020057_bib18","first-page":"385A","article-title":"Mutation rate of hepatitis C virus in patients during ribavirin monotherapy","volume":"40","author":"Lutchman","year":"2004","journal-title":"Hepatology"},{"key":"10.1124\/mol.105.020057_bib19","doi-asserted-by":"crossref","first-page":"46094","DOI":"10.1074\/jbc.C100349200","article-title":"Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin","volume":"276","author":"Maag","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.020057_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0042-6822(81)90060-X","article-title":"Inhibitors of IMP dehydrogenase prevent Sindbis virus replication and reduce GTP levels in Aedes albopictus cells","volume":"110","author":"Malinoski","year":"1981","journal-title":"Virology"},{"key":"10.1124\/mol.105.020057_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0166-3542(96)89697-5","article-title":"Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections","volume":"30","author":"Neyts","year":"1996","journal-title":"Antiviral Res"},{"key":"10.1124\/mol.105.020057_bib22","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.1128\/JVI.77.12.7131-7138.2003","article-title":"Mutagenesis versus inhibition in the efficiency of extinction of foot-and-mouth disease virus","volume":"77","author":"Pariente","year":"2003","journal-title":"J Virol"},{"key":"10.1124\/mol.105.020057_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0168-8278(04)90062-1","article-title":"Is ribavirin antiviral effect in humans mediated b mutagenic properties resulting in error catastrophe?","volume":"40","author":"Pawlotsky","year":"2004","journal-title":"J Hepatol"},{"key":"10.1124\/mol.105.020057_bib24","unstructured":"Pawlotsky JM, Chevaliez S, Brillet R, Hezode C, and Dhumeaux D (2005) Assessment of ribavirin mutagenic properties in vivo and the influence of interferon alpha-induced reduction of hepatitis C virus load upon therapy, in Proceedings of the 12th International Symposium on Hepatitis C Virus and Related Viruses; 2005 October 2-6; Montr\u00e9al, QC, Canada. Abstract 0-14."},{"key":"10.1124\/mol.105.020057_bib25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jhep.2005.07.003","article-title":"Mutagenic effects of ribavirin in vivo","volume":"43","author":"Perelson","year":"2005","journal-title":"J Hepatol"},{"key":"10.1124\/mol.105.020057_bib26","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1073\/pnas.1232294100","article-title":"A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity","volume":"100","author":"Pfeiffer","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.105.020057_bib27","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/JVI.78.2.1032-1038.2004","article-title":"High fidelity of yellow fever virus RNA polymerase","volume":"78","author":"Pugachev","year":"2004","journal-title":"J Virol"},{"key":"10.1124\/mol.105.020057_bib28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0042-6822(89)90413-3","article-title":"Studies on the mechanism of the antiviral activity of ribavirin against reovirus","volume":"168","author":"Rankin","year":"1989","journal-title":"Virology"},{"key":"10.1124\/mol.105.020057_bib29","first-page":"496","article-title":"A simple method of estimating 50 per cent end-points","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"10.1124\/mol.105.020057_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0042-6822(02)00046-6","article-title":"Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV)","volume":"308","author":"Ruiz-Jarabo","year":"2003","journal-title":"Virology"},{"key":"10.1124\/mol.105.020057_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0042-6822(87)90230-3","article-title":"Sindbis virus mutants resistant to mycophenolic acid and ribavirin","volume":"158","author":"Scheidel","year":"1987","journal-title":"Virology"},{"key":"10.1124\/mol.105.020057_bib32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/0042-6822(91)90881-B","article-title":"Mutations that confer resistance to mycophenolic acid and ribavirin on Sindbis virus map to the nonstructural protein nsP1","volume":"181","author":"Scheidel","year":"1991","journal-title":"Virology"},{"key":"10.1124\/mol.105.020057_bib33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/135965350300800603","article-title":"The potentiating effect of ribavirin on interferon in the treatment of hepatitis C: lack of evidence for ribavirin-induced viral mutagenesis","volume":"8","author":"Schinkel","year":"2003","journal-title":"Antivir Ther"},{"key":"10.1124\/mol.105.020057_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1128\/JVI.77.1.481-488.2003","article-title":"Ribavirin causes error catastrophe during Hantaan virus replication","volume":"77","author":"Severson","year":"2003","journal-title":"J Virol"},{"key":"10.1124\/mol.105.020057_bib35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.177.4050.705","article-title":"Broad-spectrum antiviral activity of Virazole: 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide","volume":"177","author":"Sidwell","year":"1972","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.105.020057_bib36","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1073\/pnas.70.4.1174","article-title":"Mechanism of action of 1-\u03b2-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent","volume":"70","author":"Streeter","year":"1973","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.105.020057_bib37","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1021\/jm00281a014","article-title":"Design, synthesis and broad spectrum antiviral activity of 1-\u03b2-d-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides","volume":"15","author":"Witkowski","year":"1972","journal-title":"J Med Chem"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2406807X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2406807X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.105.020057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T09:06:40Z","timestamp":1740042400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X2406807X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0026895X2406807X"],"URL":"https:\/\/doi.org\/10.1124\/mol.105.020057","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Anti-Yellow Fever Virus Activity of Ribavirin Is Independent of Error-Prone Replication","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.105.020057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}